Compounded "semaglutide" is not FDA approved semaglutide.com What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B Beyond the Headlines: FDA Warning Letters to GLP 1 Compounders Spencer Fane FDA Drug Recalls and Warnings: Compounding Pharmacies Cited for Unsanitary Conditions and Safety Lapses MedShadow Foundation The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide